Genetic alterations in cervical cancer : consequences for gene regulation and clinical outcome after chemoradiotherapy
Metadata
Show metadataAppears in the following Collection
- Institutt for klinisk medisin [10950]
Abstract
No abstract.List of papers
I Lyng H, Lando M, Brøvig RS, Svendsrud DH, Johansen M, Galteland E., Brustugun OT, Meza-Zepeda LA, Myklebost O, Kristensen GB, Hovig E, Stokke T (2008). GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data. Genome Biol 9(5):R86. The published version of this paper is available at: https://doi.org/10.1186/gb-2008-9-5-r86 |
II Lando M, Holden M, Bergersen LC, Svendsrud DH, Stokke T, Sundfør K, Glad IK, Kristensen GB, Lyng H (2009). Gene dosage, expression and ontology analysis identifies driver genes in the carcinogenesis and chemoradioresistance of cervical cancer. PLOS Genetics, 5(11):e1000719. The published version of this paper is available at: https://doi.org/10.1371/journal.pgen.1000719 |
III Lando M, Snipstad K, Clancy T, Halle C, Holden M, Stokke T, Sundfør K, Holm R, Kristensen GB, Lyng H. Microarray based analysis of gene expression and pathways associated with loss on chromosome 3p in cervical cancer. Manuscript. The paper is removed from the thesis in DUO due to publisher restrictions. |